Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Tuppin

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Archives of Cardiovascular Diseases|December 4, 2024
Epidemiology of venous thromboembolism in FranceAmélie Gabet, Jacques Blacher, Philippe Tuppin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) studyMarie C Iliou, Christine Fumeron, Marie O Benoit, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?Amélie Gabet, Clémence Grave, Philippe Tuppin, et al.
BMC Primary Care|August 9, 2022
Underuse of primary healthcare in France during the COVID-19 epidemic in 2020 according to individual characteristics: a national observational studyPhilippe Tuppin, Thomas Lesuffleur, Panayotis Constantinou, et al.
Pharmacoepidemiology and Drug Safety|October 15, 2010
Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitusAlain Weill, Michel Païta, Philippe Tuppin, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 9, 2023
Benefits of Cardiac Rehabilitation in Cardio-Renal Patients With Heart Failure With Reduced Ejection FractionAhmad Mroué, Stéphane Roueff, Isabella Vanorio-Vega, et al.
Archives of Cardiovascular Diseases|June 18, 2013
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010Philippe Tuppin, Pauline Ricci-Renaud, Christine de Peretti, et al.
Applied Health Economics and Health Policy|December 4, 2018
A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control StudyMehdi Touat, Marion Opatowski, Christian Brun-Buisson, et al.
Archives of Cardiovascular Diseases|December 4, 2024
Epidemiology of valvular heart disease in FranceClémence Grave, Amélie Gabet, Christophe Tribouilloy, et al.
JMIR Research Protocols|May 13, 2017
Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study ProposalMarie-Annick Le Pogam, Catherine Quantin, Oliver Reich, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Archives of Cardiovascular Diseases|December 4, 2024
Epidemiology of venous thromboembolism in FranceAmélie Gabet, Jacques Blacher, Philippe Tuppin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) studyMarie C Iliou, Christine Fumeron, Marie O Benoit, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?Amélie Gabet, Clémence Grave, Philippe Tuppin, et al.
BMC Primary Care|August 9, 2022
Underuse of primary healthcare in France during the COVID-19 epidemic in 2020 according to individual characteristics: a national observational studyPhilippe Tuppin, Thomas Lesuffleur, Panayotis Constantinou, et al.
Pharmacoepidemiology and Drug Safety|October 15, 2010
Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitusAlain Weill, Michel Païta, Philippe Tuppin, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 9, 2023
Benefits of Cardiac Rehabilitation in Cardio-Renal Patients With Heart Failure With Reduced Ejection FractionAhmad Mroué, Stéphane Roueff, Isabella Vanorio-Vega, et al.
Archives of Cardiovascular Diseases|June 18, 2013
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010Philippe Tuppin, Pauline Ricci-Renaud, Christine de Peretti, et al.
Applied Health Economics and Health Policy|December 4, 2018
A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control StudyMehdi Touat, Marion Opatowski, Christian Brun-Buisson, et al.
Archives of Cardiovascular Diseases|December 4, 2024
Epidemiology of valvular heart disease in FranceClémence Grave, Amélie Gabet, Christophe Tribouilloy, et al.
JMIR Research Protocols|May 13, 2017
Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study ProposalMarie-Annick Le Pogam, Catherine Quantin, Oliver Reich, et al.
Pageof 13